News & Events
The next Atlas of MS is underway
MSIF’s Atlas of MS with new data on the number of people living with MS across the…
India’s bikers against MS
The MS Society of India celebrated India MS Day with a national bike rally. Learn more about…
Music legend Masta Ace: hip-hop, MS and getting creative
The UK MS Society met up with Brooklyn rapper and record producer Masta Ace to talk about…
European Medicines Agency reviews safety of alemtuzumab
EMA conducts safety review of alemtuzumab (Lemtrada)
Cladribine approved in US for people with active secondary progressive MS
FDA approves cladribine for people with relapsing forms of MS and active secondary progressive MS
Treatment licensed in US for people with active secondary progressive MS
FDA approves the drug Siponimod, to treat people with active secondary progressive MS
How different disease modifying therapies can delay progression
A new study examined different disease modifying therapies and their ability to slow the onset of secondary…
Treating MS in pregnancy
MS affects at least twice as many more women than men, and it often strikes at an…
Screening environmental chemicals that may influence MS
976 chemicals were screened to assess their impact on MS.
Stem cell trial results published
A trial has compared a cancer chemotherapy to MS treatments, but further research is needed to understand…
Let’s talk about sex and MS
We have collaborated with our members to adapt an animation that addresses some of the challenges of…
EME’s Tips to Help Quality of Life
Multiple Sclerosis Spain has launched a new illustration with tips to help improve quality of life for…